Philip Morris International Inc. to Repurchase 2.625% Notes Due 2022 | News

NEW YORK – (BUSINESS WIRE) – December 13, 2021–

Regulatory news:

Philip Morris International Inc. (NYSE: PM) (“PMI”) announced today that it will redeem all of its outstanding 2.625% Notes due February 18, 2022 (the “Notes”) on January 18, 2022 ( the “redemption date”). The Notes are listed on the New York Stock Exchange under the symbol “PM22A” and are assigned the numbers CUSIP 718172 BZ1 and ISIN US718172BZ15. As of December 13, 2021, an aggregate principal amount of $ 500,000,000 of the Notes was outstanding. On the Redemption Date, PMI will pay to registered holders of the Notes a redemption price equal to 100% of the principal amount of the Notes, plus accrued and unpaid interest, if any, up to the Redemption Date, but at the same time. ‘exclusion.

This press release does not constitute a notice of redemption of the Notes. Noteholders should refer to the redemption notice provided to registered holders of the Notes by HSBC Bank USA, National Association, the trustee of the Notes.

Philip Morris International: Providing a Smoke-Free Future

Philip Morris International (PMI) is leading a transformation of the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smokeless products for the benefit of adults who would otherwise continue to smoke, society, of the company, its shareholders and other stakeholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smokeless products, related electronic devices and accessories, and other nicotine-containing products in out-of-state markets. -United. IQOS Platform 1 device and consumables have received marketing authorizations from the United States Food and Drug Administration (FDA) through the Pre-Market Tobacco Product Application (PMTA) process ; the FDA has also cleared a version of IQOS and its consumables as a modified risk tobacco product (MRTP), believing that an exposure modification order for these products is appropriate to promote public health. PMI is building a future on a new category of smoke-free products which, while not without risk, are a much better choice than to continue to smoke. With multidisciplinary capabilities in product development, state-of-the-art facilities and scientific rationale, PMI aims to ensure that its smoke-free products meet the preferences of adult consumers and meet stringent regulatory requirements. PMI’s smoke-free product portfolio includes products that do not burn, vapor products containing nicotine, and oral nicotine products. As of September 30, 2021, PMI’s smoke-free products are available for sale in 70 markets in key cities or nationwide, and PMI estimates that approximately 14.9 million adults worldwide have already switched to IQOS and quit smoking. For more information, please visit www.pmi.com and www.pmiscience.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20211213005373/en/

CONTACT: Philip Morris International

Investor Relations:

New-York: +1 (917) 663 2233

Lausanne: +41 (0) 58 242 4666

Email: [email protected] Media:

Lausanne: +41 (0) 58 242 4500

Email: [email protected]

KEYWORD: UNITED STATES NORTH AMERICA CANADA NEW YORK

INDUSTRY KEYWORD: TOBACCO DETAILS

SOURCE: Philip Morris International

Copyright Business Wire 2021.

PUB: 12/13/2021 6:15 a.m. / DISC: 12/13/2021 6:17 a.m.

http://www.businesswire.com/news/home/20211213005373/en

Copyright Business Wire 2021.


Source link

Comments are closed.